Logo image of ALSPW.PA

SPINEWAY (ALSPW.PA) Stock Fundamental Analysis

EPA:ALSPW - Euronext Paris - Matif - FR001400N2P2 - Common Stock - Currency: EUR

0.1212  -0.01 (-4.72%)

Fundamental Rating

3

ALSPW gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 58 industry peers in the Health Care Equipment & Supplies industry. The financial health of ALSPW is average, but there are quite some concerns on its profitability. ALSPW is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

ALSPW had negative earnings in the past year.
In the past year ALSPW has reported a negative cash flow from operations.
In the past 5 years ALSPW always reported negative net income.
ALSPW had a negative operating cash flow in each of the past 5 years.
ALSPW.PA Yearly Net Income VS EBIT VS OCF VS FCFALSPW.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5M -10M

1.2 Ratios

ALSPW has a Return On Assets of -12.71%. This is in the lower half of the industry: ALSPW underperforms 65.52% of its industry peers.
Looking at the Return On Equity, with a value of -15.94%, ALSPW is doing worse than 63.79% of the companies in the same industry.
ALSPW has a Return On Invested Capital of 0.90%. This is in the lower half of the industry: ALSPW underperforms 62.07% of its industry peers.
Industry RankSector Rank
ROA -12.71%
ROE -15.94%
ROIC 0.9%
ROA(3y)-16.26%
ROA(5y)-30.05%
ROE(3y)-21.45%
ROE(5y)-42.44%
ROIC(3y)N/A
ROIC(5y)N/A
ALSPW.PA Yearly ROA, ROE, ROICALSPW.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

1.3 Margins

ALSPW has a worse Operating Margin (2.69%) than 62.07% of its industry peers.
ALSPW's Gross Margin of 70.73% is fine compared to the rest of the industry. ALSPW outperforms 77.59% of its industry peers.
In the last couple of years the Gross Margin of ALSPW has grown nicely.
Industry RankSector Rank
OM 2.69%
PM (TTM) N/A
GM 70.73%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.32%
GM growth 5Y16.07%
ALSPW.PA Yearly Profit, Operating, Gross MarginsALSPW.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

More info and screens

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ALSPW is destroying value.
Compared to 1 year ago, ALSPW has more shares outstanding
ALSPW has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, ALSPW has an improved debt to assets ratio.
ALSPW.PA Yearly Shares OutstandingALSPW.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
ALSPW.PA Yearly Total Debt VS Total AssetsALSPW.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

Based on the Altman-Z score of 0.58, we must say that ALSPW is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of ALSPW (0.58) is worse than 67.24% of its industry peers.
ALSPW has a Debt/Equity ratio of 0.07. This is a healthy value indicating a solid balance between debt and equity.
ALSPW's Debt to Equity ratio of 0.07 is amongst the best of the industry. ALSPW outperforms 86.21% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF N/A
Altman-Z 0.58
ROIC/WACC0.22
WACC4.16%
ALSPW.PA Yearly LT Debt VS Equity VS FCFALSPW.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

2.3 Liquidity

A Current Ratio of 3.28 indicates that ALSPW has no problem at all paying its short term obligations.
The Current ratio of ALSPW (3.28) is better than 82.76% of its industry peers.
ALSPW has a Quick Ratio of 2.17. This indicates that ALSPW is financially healthy and has no problem in meeting its short term obligations.
With a decent Quick ratio value of 2.17, ALSPW is doing good in the industry, outperforming 77.59% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.28
Quick Ratio 2.17
ALSPW.PA Yearly Current Assets VS Current LiabilitesALSPW.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

5

3. Growth

3.1 Past

ALSPW shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 99.95%, which is quite impressive.
ALSPW shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 13.60%.
The Revenue has been growing by 18.95% on average over the past years. This is quite good.
EPS 1Y (TTM)99.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.97%
Revenue 1Y (TTM)13.6%
Revenue growth 3Y40.7%
Revenue growth 5Y18.95%
Sales Q2Q%6.45%

3.2 Future

The Earnings Per Share is expected to decrease by -41.42% on average over the next years. This is quite bad
The Revenue is expected to grow by 40.08% on average over the next years. This is a very strong growth
EPS Next Y-100.02%
EPS Next 2Y-41.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2Y40.08%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ALSPW.PA Yearly Revenue VS EstimatesALSPW.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2026 5M 10M 15M
ALSPW.PA Yearly EPS VS EstimatesALSPW.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2021 2022 2023 2024 2025 0 -5M -10M -15M -20M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALSPW. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ALSPW. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALSPW.PA Price Earnings VS Forward Price EarningsALSPW.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -1.99
ALSPW.PA Per share dataALSPW.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

ALSPW's earnings are expected to decrease with -41.42% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-41.42%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALSPW!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SPINEWAY

EPA:ALSPW (6/27/2025, 7:00:00 PM)

0.1212

-0.01 (-4.72%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-24 2025-03-24/amc
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap100.60K
Analysts86.67
Price Target0.36 (197.03%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-73.08%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.01
P/FCF N/A
P/OCF N/A
P/B 0
P/tB 0.01
EV/EBITDA -1.99
EPS(TTM)-0.99
EYN/A
EPS(NY)-0.01
Fwd EYN/A
FCF(TTM)-5.16
FCFYN/A
OCF(TTM)-3.95
OCFYN/A
SpS14.4
BVpS29.21
TBVpS17.75
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -12.71%
ROE -15.94%
ROCE 1.23%
ROIC 0.9%
ROICexc 1.08%
ROICexgc 1.92%
OM 2.69%
PM (TTM) N/A
GM 70.73%
FCFM N/A
ROA(3y)-16.26%
ROA(5y)-30.05%
ROE(3y)-21.45%
ROE(5y)-42.44%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.32%
GM growth 5Y16.07%
F-Score4
Asset Turnover0.39
Health
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF N/A
Debt/EBITDA 1.31
Cap/Depr 95.56%
Cap/Sales 8.46%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.28
Quick Ratio 2.17
Altman-Z 0.58
F-Score4
WACC4.16%
ROIC/WACC0.22
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)99.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.97%
EPS Next Y-100.02%
EPS Next 2Y-41.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)13.6%
Revenue growth 3Y40.7%
Revenue growth 5Y18.95%
Sales Q2Q%6.45%
Revenue Next YearN/A
Revenue Next 2Y40.08%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y108.99%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y26.43%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y43.79%
OCF growth 3YN/A
OCF growth 5YN/A